Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
10/03/1996 | WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
10/03/1996 | WO1996023489A3 Use of carotinoids for preparing medicaments for treating dermatoses |
10/03/1996 | WO1994004702A3 Improved detection and therapy of lesions with biotin/avidin conjugates |
10/03/1996 | CA2216728A1 Azathioprine compositions for colonic administration |
10/03/1996 | CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
10/03/1996 | CA2215160A1 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases |
10/03/1996 | CA2214988A1 Method of treating inflammation and compositions therefor |
10/03/1996 | CA2189656A1 New peptides with immunomodulatory effects |
10/02/1996 | EP0735038A1 Protein kinase C inhibitors |
10/02/1996 | EP0734394A1 Peptide inhibitors of cxc intercrine molecules |
10/02/1996 | EP0734386A1 Platelet activating factor antagonists: imidazopyridine indoles |
10/02/1996 | EP0734381A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
10/02/1996 | EP0734376A1 Vitamin d amine and amide derivatives |
10/02/1996 | EP0734256A1 Di-tert-butylphenol compounds useful as anti-inflammatory agents |
10/02/1996 | EP0734248A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
10/02/1996 | EP0653943A4 Targeting somatic gene therapy to joints. |
10/02/1996 | CN1132512A C-22 ring stabilized rapamycin derivatives |
10/02/1996 | CN1132511A Matrix metalloprotease inhibitors |
10/02/1996 | CN1132479A Mycophenolate mofetil high dose oral suspensions |
10/02/1996 | CN1132206A Pyrrole derivatives |
10/02/1996 | CN1132202A New benzopyran derivatives, their process of preparation and pharmaceutical compositions which contain them |
10/01/1996 | US5561228 Immunosuppressnats; side effect reduction |
10/01/1996 | US5561148 Oxazolidine derivative |
10/01/1996 | US5561146 Modified guanidino and amidino thrombin inhibitors |
10/01/1996 | US5561132 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
10/01/1996 | US5561130 Azacyclic compounds |
10/01/1996 | US5561113 Analgesics; antiiflammatory agents; gastrointestinal, urogenital and nervous system(cns) disorders; asthma; antiallergens |
10/01/1996 | US5560935 Administering to inhibit plasma kallikrein production: improves peripheral blood flow, exhibits analgesic, antiinflammatory and antiallergic properties |
10/01/1996 | CA2033499C Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
10/01/1996 | CA1338625C Tricyclic compounds |
09/26/1996 | WO1996029408A1 Il-17 receptor |
09/26/1996 | WO1996029407A2 Cellubrevin homologs |
09/26/1996 | WO1996029339A1 Fucopeptides |
09/26/1996 | WO1996029328A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents |
09/26/1996 | WO1996029317A1 Aromatic compounds useful as tachykinin antagonists |
09/26/1996 | WO1996029315A2 Imidazole derivatives as histamine receptor h3 (ant)agonists |
09/26/1996 | WO1996029313A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
09/26/1996 | WO1996029304A1 Nonpeptides as tachykinin antagonists |
09/26/1996 | WO1996029080A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
09/26/1996 | WO1996029077A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system |
09/26/1996 | WO1996029056A1 Topically applied pharmaceutical composition, method of preparing it and its use |
09/26/1996 | DE4396528C1 Abalone shell powder and sesame oil compsn for burn treatment |
09/26/1996 | CA2216147A1 Cellubrevin homologs |
09/26/1996 | CA2215700A1 Aromatic compounds useful as tachykinin antagonists |
09/26/1996 | CA2215699A1 Morpholine derivatives, compositions containing them and their use as therapeutic agents |
09/26/1996 | CA2214107A1 Fucopeptides |
09/26/1996 | CA2211191A1 Nonpeptides as tachykinin antagonists |
09/26/1996 | CA2211179A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system |
09/26/1996 | CA2190865A1 Imidazole derivatives as histamine receptor h3 (ant)agonists |
09/25/1996 | EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
09/25/1996 | EP0733071A1 Antagonists to chaperonin 10 |
09/25/1996 | EP0733069A1 Purified primate ctla-8 antigens and related reagents |
09/25/1996 | EP0733066A1 Pretargeting methods and compounds |
09/25/1996 | EP0733065A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
09/25/1996 | EP0733051A1 Bicyclic heterocycles as neurokinin a antagonists |
09/25/1996 | EP0733049A1 Tricyclic derivatives and their use in pharmaceuticals |
09/25/1996 | EP0733047A1 Novel substituted oxazolidines |
09/25/1996 | EP0733044A1 Compounds |
09/25/1996 | EP0733043A1 Tricyclic derivatives and their use in pharmaceuticals |
09/25/1996 | EP0733035A1 Tricyclic derivatives, pharmaceutical compositions containing them |
09/25/1996 | EP0733033A1 Pharmaceutically active substituted aromatic compounds |
09/25/1996 | EP0732944A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
09/25/1996 | EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
09/25/1996 | EP0732940A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
09/25/1996 | EP0732938A1 Method of treating intestinal disorders |
09/25/1996 | EP0732929A1 Therapeutic use of cis-element decoys in vivo |
09/25/1996 | EP0732919A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4 |
09/25/1996 | EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
09/25/1996 | CN1131675A Grosslinked acidic polysaccharides and their uses |
09/25/1996 | CN1131665A Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation |
09/25/1996 | CN1131557A Chinese medicine pill for treating rheumatoid disease |
09/24/1996 | US5559232 Anticoagulants |
09/24/1996 | US5559137 Pyrazoles, arthritis treatment |
09/24/1996 | US5559136 Treatment of Alzheimer's disease using azacyclic compounds |
09/24/1996 | US5559130 Pyrrolidinyl pyridones for treating pain |
09/24/1996 | US5559123 Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same |
09/24/1996 | US5559122 Hindered N-oxide esters of rapamycin |
09/24/1996 | US5558085 Intrapulmonary delivery of peptide drugs |
09/19/1996 | WO1996028552A1 Rheumatoid arthritis-related virus msrv-1 and pathogenic and/or infective agent msrv-2 |
09/19/1996 | WO1996028547A1 Dermatomyositis-specific auto-antigen |
09/19/1996 | WO1996028544A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
09/19/1996 | WO1996028472A1 Antigen composition against mycoplasma |
09/19/1996 | WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
09/19/1996 | WO1996028430A1 Trisubstituted phenyl derivatives |
09/19/1996 | WO1996028187A1 Method for treating amyloidosis |
09/19/1996 | WO1996028186A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
09/19/1996 | WO1996028160A1 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties |
09/19/1996 | WO1996028156A1 Novel benzothiophene compounds and methods |
09/19/1996 | WO1996019499A3 Improved cyclic crf antagonists |
09/19/1996 | WO1996019233A3 Irrigation solution and method for inhibition of pain, inflammation and spasm |
09/19/1996 | WO1996010999A3 Lta4 hydrolase inhibitor pharmaceutical compositions and methods of use |
09/19/1996 | CA2215046A1 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties |
09/19/1996 | CA2214850A1 Novel benzothiophene compounds and methods |
09/19/1996 | CA2214799A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
09/18/1996 | EP0732331A1 Novel benzothiophene compounds and methods for inhibiting lipoxygenase and leukotrienes |
09/18/1996 | EP0732328A1 Aromatic heterocyclic compounds, pharmaceutical and cosmetic compositions containing them and their uses |
09/18/1996 | EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
09/18/1996 | EP0731811A1 Chaperonin 10 |
09/18/1996 | EP0731796A1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation |
09/18/1996 | EP0731795A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |